Hypertension, Pulmonary
161
5
9
109
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
37 trials with published results (23%)
Research Maturity
109 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
11.8%
19 terminated out of 161 trials
85.2%
-1.4% vs benchmark
27%
44 trials in Phase 3/4
34%
37 of 109 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 109 completed trials
Clinical Trials (161)
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
Riociguat in Children With Pulmonary Arterial Hypertension (PAH)
Vasopressor Agents in Pulmonary Hypertension Crisis
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults (DHEA-HTAP)
Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults
Pulmonary Artery Remodelling With Bosentan
Inflammatory Biomarkers of Pediatric Pulmonary Hypertension
A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)
A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary Hypertension
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.
Functional Pulmonary Capillary Surface Area in BPA for CTEPH
A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH)
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)